Analyst Reco. Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2026-05-15 pm EDT			5-day change	1st Jan Change
52.68 ^USD	-1.62%		-2.32%	-44.75%

May. 07	Boston Scientific to Update Pacemakers in Recall, FDA Says	DJ
May. 07	US FDA issues recall of Boston Scientific heart devices	RE

Analyst Reco.

Apr. 29	Boston Scientific Shares Fall After Daiwa Securities Downgrade	MT
Apr. 29	Daiwa Securities Downgrades Boston Scientific to Neutral From Outperform, Adjusts PT to $60 From $83	MT
Apr. 27	UBS Adjusts Boston Scientific Price Target to $95 From $105, Maintains Buy Rating	MT
Apr. 27	Argus Research Adjusts Boston Scientific Price Target to $95 From $115, Maintains Buy Rating	MT
Apr. 23	Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says	MT
Apr. 23	Oppenheimer Adjusts Boston Scientific Price Target to $90 From $100, Maintains Outperform Rating	MT
Apr. 23	Deutsche Bank Cuts Price Target on Boston Scientific to $75 From $90, Keeps Buy Rating	MT
Apr. 23	Truist Lowers Price Target on Boston Scientific to $85 From $90, Keeps Buy Rating	MT
Apr. 23	BTIG Research Adjusts Boston Scientific Price Target to $80 From $90, Maintains Buy Rating	MT
Apr. 23	TD Cowen Adjusts Boston Scientific Price Target to $80 From $100, Maintains Buy Rating	MT
Apr. 23	Canaccord Genuity Adjusts Boston Scientific Price Target to $71 From $109, Maintains Buy Rating	MT
Apr. 23	Needham & Co Adjusts Boston Scientific PT to $77 From $97, Maintains Buy Rating	MT
Apr. 23	Goldman Sachs Adjusts Boston Scientific Price Target to $84 From $87, Maintains Buy Rating	MT
Apr. 23	Jefferies & Co Adjusts Boston Scientific PT to $100 From $110, Maintains Buy Rating	MT
Apr. 23	Bernstein Adjusts Price Target on Boston Scientific to $97 From $112, Maintains Outperform Rating	MT
Apr. 23	Raymond James Adjusts Price Target on Boston Scientific to $78 From $88, Maintains Outperform Rating	MT
Apr. 23	Baird Adjusts Price Target on Boston Scientific to $78 From $86, Maintains Outperform Rating	MT
Apr. 23	Leerink Partners Adjusts Price Target on Boston Scientific to $86 From $89, Maintains Outperform Rating	MT
Apr. 23	Evercore ISI Adjusts Price Target on Boston Scientific to $78 From $80, Maintains Outperform Rating	MT
Apr. 23	JPMorgan Adjusts Price Target on Boston Scientific to $80 From $100, Maintains Overweight Rating	MT
Apr. 23	RBC Trims Price Target on Boston Scientific to $100 From $105, Keeps Outperform Rating	MT
Apr. 23	Barclays Adjusts Price Target on Boston Scientific to $96 From $100, Maintains Overweight Rating	MT
Apr. 23	Rothschild & Co Redburn Adjusts PT on Boston Scientific to $106 From $110, Maintains Buy Rating	MT
Apr. 22	Evercore ISI Adjusts Boston Scientific Price Target to $78 From $80, Maintains Outperform Rating	MT
Apr. 22	Wells Fargo Adjusts Price Target on Boston Scientific to $75 From $94, Maintains Overweight Rating	MT